ACAD Competitors & Alternatives
Compare ACADIA Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ACAD
Main Stock$24.84
Tradestie Score
53
Market Cap
$3.58B
P/E Ratio
11.3
Revenue Growth
0.1%
Analyst Upside
+32.0%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTCT
PTC Therapeutics, Inc.
|
$76.82
|
$4.93B | - | 58 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$85.60
|
$4.84B | - | 53 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$136.11
|
$3.98B | - | 57 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.73
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.57
|
$3.91B | - | 54 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.22
|
$3.83B | - | 46 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.29
|
$3.68B | - | 43 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$113.03
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.27
|
$3.59B | 12.3 | 48 | Compare |
More ACAD Analysis
Data updated: Jul 27, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry